Tuesday, August 12, 2014
XIAFLEX and Peyronie's disease
Xiaflex is the first FDA-approved drug for the treatment of Peyronie's disease. The drug, collagenase clostridium histolyticum, had previously been approved as a treatment for Dupuytren's contracture. Xiaflex acts by breaking up the collagen scar tissue and allowing for remodeling of the scar with improvement of the penile curvature. Candidates for Xiaflex injection would be a man with stable disease, Peyronie's disease for at least 12 months and a curvature of 30 degrees or more. Xiaflex is a product of Auxilium pharmaceuticals. Xiaflex is available through urologists participating in the REMS program for Peyronie's Disease.
Tuesday, January 14, 2014
More on EMR
In the NYT article-"A Busy Doctor's Right Hand"-1/14/14, I am amazed how the burden of EMR is magically solved in some corporate boardroom or home garage.
The result is the absurd entity known as a "scribe". A non-professional hired to shadow and assist the physician by insinuating and infiltrating the private domain of Medicine. While assisting the physician with cumbersome tasks of entering data, the scribe will only further fracture the personal doctor-patient relationship which is already severely damaged. Shame on those in the corporate world who concocted this pathetic entity and to those who subscribe to this service. Yes, the problems of EMR were answered with this "Band-Aid" of a solution. Yet, the root of the problem is once again ignored.
The result is the absurd entity known as a "scribe". A non-professional hired to shadow and assist the physician by insinuating and infiltrating the private domain of Medicine. While assisting the physician with cumbersome tasks of entering data, the scribe will only further fracture the personal doctor-patient relationship which is already severely damaged. Shame on those in the corporate world who concocted this pathetic entity and to those who subscribe to this service. Yes, the problems of EMR were answered with this "Band-Aid" of a solution. Yet, the root of the problem is once again ignored.
Subscribe to:
Posts (Atom)